Williams & Novak’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$290K Sell
1,094
-549
-33% -$145K 0.17% 101
2026
Q2
$417K Buy
1,643
+610
+59% +$142K 0.28% 81
2026
Q1
$252K Buy
+1,033
New +$241K 0.19% 95
2025
Q1
– Sell
-1,456
Closed -$211K – 141
2024
Q4
$211K Sell
1,456
-1,249
-46% -$194K 0.2% 102
2024
Q3
$438K Hold
2,705
– – 0.41% 65
2024
Q2
$395K Buy
2,705
+1,100
+69% +$164K 0.37% 64
2024
Q1
$252K Hold
1,605
– – 0.29% 71
2023
Q4
$252K Buy
+1,605
New +$246K 0.29% 71

Other funds holding JNJ

Williams & Novak's JNJ Position: Q3 2026 in Review

Williams & Novak reduced its Johnson & Johnson (JNJ) stake by 33% in Q3 2026, selling an estimated $145K and leaving 1,094 shares worth $290K. The position accounts for 0.17% of the portfolio, ranked #101.

Williams & Novak first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. The position peaked at $438K in Q3 2024. 267 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Williams & Novak held 1,094 shares of Johnson & Johnson worth $290K as of Q3 2026.
  • Williams & Novak sold 549 Johnson & Johnson shares in Q3 2026, an estimated $145K.
  • Johnson & Johnson made up 0.17% of Williams & Novak's portfolio in Q3 2026, its #101 holding.
  • Williams & Novak first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • Williams & Novak's Johnson & Johnson position peaked at $438K in Q3 2024.
  • 267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.